Alnylam Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2834 http://www.alnylam.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY - Sep 18th, 2018 5:30 pm
ALNYLAM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alnylam Pharmaceuticals, Inc. To Contact The Firm - Sep 14th, 2018 3:23 pm
What Solid Biosciences’ Valuation Trend Indicates - Sep 14th, 2018 12:54 pm
Why Dicerna Pharmaceuticals Stock Rose 7.7% Yesterday - Sep 14th, 2018 8:24 am
Alnylam Investigation: Bernstein Liebhard LLP Announces Investigation of Alnylam Pharmaceuticals, Inc. - ALNY - Sep 14th, 2018 5:30 am
Alnylam Announces Publication in Circulation of Exploratory Cardiac Endpoint Data from APOLLO Phase 3 Study of Patisiran - Sep 14th, 2018 4:00 am
Alnylam Investigation: Bernstein Liebhard LLP Announces Investigation Of Alnylam Pharmaceuticals, Inc. - ALNY - Sep 13th, 2018 1:38 pm
Bragar Eagel & Squire, P.C. is Investigating Alnylam Pharmaceuticals, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm - Sep 13th, 2018 12:42 pm
What Sarepta Therapeutics’ Valuation Trend Indicates - Sep 13th, 2018 12:03 pm
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alnylam Pharmaceuticals, Inc. (ALNY) - Sep 12th, 2018 12:14 pm
Here's Why Dicerna Pharmaceuticals, Inc. Is on a Roller Coaster; Down 18% Yesterday, Up 17% Today - Sep 7th, 2018 12:32 pm
See what the IHS Markit Score report has to say about Alnylam Pharmaceuticals Inc. - Sep 7th, 2018 6:07 am
How’s Alkermes Positioned Financially in September? - Sep 5th, 2018 11:50 am
Alkermes: Analysts’ View in September - Sep 5th, 2018 10:19 am
What you missed on your summer vacation in Mass. biotech news - Sep 4th, 2018 3:36 am
Alnylam Gets European Nod for First-Ever RNAi Therapeutic - Aug 31st, 2018 2:05 pm
Alnylam Receives Approval of ONPATTRO™ (patisiran) in Europe - Aug 30th, 2018 5:00 am
Alnylam to Webcast Presentations at Upcoming September Investor Conferences - Aug 29th, 2018 7:00 am